Sign in

CIK 0001858848

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Tenaya Therapeutics, Inc.

Sign in to watch
Ticker
TNYA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813789973
Phone
+1 415-865-2066
Business address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-01-24 Tingley Whittemore Chief Medical Officer Grant or award · Stock Option (Right to Buy) +69,982 69,982
2025-01-24 Tingley Whittemore Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −141,000 0
2025-01-24 Tingley Whittemore Chief Medical Officer Grant or award · Stock Option (Right to Buy) +141,000 141,000
2025-01-24 Tingley Whittemore Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −205,000 0
2025-01-24 Tingley Whittemore Chief Medical Officer Grant or award · Stock Option (Right to Buy) +205,000 205,000
2025-01-24 Tingley Whittemore Chief Medical Officer Returned to the company · Stock Option (Right to Buy) −215,000 0
2025-01-24 Tingley Whittemore Chief Medical Officer Grant or award · Stock Option (Right to Buy) +215,000 215,000
2024-11-18 Saito Chihiro SVP, Accounting and Fin. Ops. Sale −2,258 $2.12 $5K 60,983
2024-10-18 Walsh Jeffrey T. Director Grant or award · Stock Option (Right to buy) +34,000 34,000
2024-10-18 Williams R Sanders Director Grant or award · Stock Option (Right to buy) +34,000 34,000
2024-10-18 Stehman-Breen Catherine Director Grant or award · Stock Option (Right to buy) +34,000 34,000
2024-10-18 Srivastava Deepak Director Grant or award · Stock Option (Right to buy) +34,000 34,000
2024-10-18 Parschauer Karah Herdman Director Grant or award · Stock Option (Right to buy) +34,000 34,000
2024-10-18 Lee June Director Grant or award · Stock Option (Right to buy) +34,000 34,000
2024-10-18 GOEDDEL DAVID V Director Grant or award · Stock Option (Right to buy) +34,000 34,000
2024-10-18 Burroughs Amy L. Director Grant or award · Stock Option (Right to buy) +34,000 34,000
2024-08-16 Saito Chihiro SVP, Accounting and Fin. Ops. Sale −902 $2.89 $3K 64,702
2024-08-16 Saito Chihiro SVP, Accounting and Fin. Ops. Sale −654 $2.89 $2K 64,048
2024-08-16 Saito Chihiro SVP, Accounting and Fin. Ops. Sale −807 $2.89 $2K 63,241
2024-08-16 Tingley Whittemore Chief Medical Officer Sale −5,803 $2.89 $17K 108,731

Page 6 of 12 · 228 trades